BASF, Catalent collaborate solve bioavailability challenges

BASF, Catalent collaborate to solve bioavailability challenges

5:48 AM, 5th April 2012
BASF, Catalent collaborate to solve bioavailability challenges

SOMERSET, US/LUDWIGSHAFEN, GERMANY: Catalent Pharma Solutions and BASF have entered into collaboration and open alliance to provide solutions to overcome bioavailability challenges of new molecular entities with solubility or permeability challenges. The companies aim to combine their world-leading expertise to provide pharmaceutical customers with a unique range of seamless solutions to address pipeline challenges with a large majority of biopharmaceutics classification system class II and IV poorly bioavailable compounds.

BASF and Catalent provide a full solution to one of the most important pipeline challenges in the industry, getting better treatments to market faster. BASF has extensive ingredient formulation and material science expertise, as well as world-class excipient products and has been a leader in developing hot melt extrusion technology solutions. Catalent is the number one global partner in drug formulation and development as well as in finished oral dose manufacturing, with more than 75 years of experience in providing bioavailability solutions.

“BASF brings significant strengths and expertise that match very well with Catalent’s expertise in offering multiple solutions for poorly soluble compounds; including our Softgel platform and OptiMelt hot melt extrusion technologies. Our proven track record of developing, scaling up and manufacturing pharmaceutical products globally also provides for an important seamless integration from development to commercialization and ongoing supply,” said Ian Muir, President, Modified Release Technology business unit, Catalent.

© WOC News

0 Comments

Login

Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News


Acron invests $95 million in urea facility in Russia

VELIKY NOVGOROD, RUSSIA: Acron launched a new urea facility unit on 31 March 2012 in Veliky Novgorod, Russia. Acron embarked on Urea-1000 project in 2 ...

Read more
Technip, CIMV joint venture for biorefinery

PARIS, FRANCE: Technip signed a cooperation agreement in the green chemistry business with the Compagnie Industrielle de la Matiere Vegetale (CIMV) to ...

Read more
Sinopec, SABIC to invest $1.7 billion in polycarbonate facility in China

JUBAIL, SAUDI ARABIA: Sinopec SABIC Tianjin Petrochemical Company (SSTPC), a 50:50 joint venture of Sinopec and SABIC, laid the foundation for a polyc ...

Read more
UOP invests $20 million for adsorbents and catalysts expansion

DES PLAINES, US: UOP LLC, a Honeywell company, will invest $20 million to expand its production facility in Mobile, Alabama, US, to produce adsorbents ...

Read more
Development of carbohydrates based medicines

SWINDON, UK: A recent breakthrough in sugar chemistry could open the door to a new generation of synthetic medicines and diagnostic tools. Carbohydrat ...

Read more
Scientists try to split oxygen from water

GEORGIA, US: Splitting hydrogen and oxygen from water using conventional electrolysis techniques requires considerable amounts of electrical energy. B ...

Read more
www.worldofchemicals.com uses cookies to ensure that we give you the best experience on our website. By using this site, you agree to our Privacy Policy and our Terms of Use. X